A detailed history of Jane Street Group, LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 204,750 shares of KPTI stock, worth $171,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares
204,750
Previous 1,549,976 86.79%
Holding current value
$171,990
Previous $1.35 Million 87.46%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.06 $941,658 - $1.43 Million
-1,345,226 Reduced 86.79%
204,750 $169,000
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.58 $1.2 Million - $2.18 Million
1,378,326 Added 802.99%
1,549,976 $1.35 Million
Q1 2024

May 15, 2024

SELL
$0.72 - $1.66 $74,743 - $172,324
-103,810 Reduced 37.69%
171,650 $259,000
Q4 2023

Feb 14, 2024

BUY
$0.68 - $1.31 $187,312 - $360,852
275,460 New
275,460 $236,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $4.59 $1.19 Million - $3.04 Million
662,363 New
662,363 $1.19 Million
Q4 2022

Feb 14, 2023

BUY
$2.48 - $5.93 $204,768 - $489,628
82,568 Added 559.1%
97,336 $330,000
Q3 2022

Nov 14, 2022

SELL
$4.08 - $5.82 $790,822 - $1.13 Million
-193,829 Reduced 92.92%
14,768 $81,000
Q3 2022

Nov 14, 2022

SELL
$4.08 - $5.82 $790,822 - $1.13 Million
-193,829 Reduced 92.92%
14,768 $81,000
Q2 2022

Aug 16, 2022

SELL
$4.15 - $8.37 $864,220 - $1.74 Million
-208,246 Reduced 49.96%
208,597 $941,000
Q1 2022

May 17, 2022

BUY
$5.91 - $14.38 $1.24 Million - $3.02 Million
209,700 Added 101.23%
416,843 $3.07 Million
Q4 2021

Feb 15, 2022

BUY
$5.21 - $8.61 $931,626 - $1.54 Million
178,815 Added 631.23%
207,143 $1.33 Million
Q3 2021

Nov 16, 2021

BUY
$4.45 - $10.63 $6,167 - $14,733
1,386 Added 5.14%
28,328 $165,000
Q2 2021

Aug 16, 2021

SELL
$8.11 - $11.11 $376,166 - $515,315
-46,383 Reduced 63.26%
26,942 $278,000
Q1 2021

May 18, 2021

BUY
$9.85 - $17.69 $23,314 - $41,872
2,367 Added 3.34%
73,325 $771,000
Q4 2020

Feb 17, 2021

SELL
$14.15 - $17.19 $162,258 - $197,117
-11,467 Reduced 13.91%
70,958 $1.1 Million
Q3 2020

Nov 17, 2020

SELL
$14.14 - $19.71 $354,829 - $494,602
-25,094 Reduced 23.34%
82,425 $1.2 Million
Q2 2020

Aug 17, 2020

BUY
$16.6 - $25.25 $1.54 Million - $2.34 Million
92,582 Added 619.82%
107,519 $2.04 Million
Q4 2019

Feb 14, 2020

SELL
$9.23 - $19.67 $59,865 - $127,579
-6,486 Reduced 30.28%
14,937 $286,000
Q3 2019

Nov 14, 2019

BUY
$5.66 - $11.85 $121,254 - $253,862
21,423 New
21,423 $206,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.